
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. (SLS)
WebsitePrice
Market cap
Next catalystDec 14, 2026SLS009 (tambiciclib) + azacitidine/venetoclax — completed r/r AML study · Phase 2 dataCompany source ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP1P2P3FilingApproved
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
History / paused
SLS PR & News
PR & News
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc.